Australia - English - Department of Health (Therapeutic Goods Administration)

ortho-clinical diagnostics australia pty ltd - 48304 - hepatitis b virus core total antibody ivd, kit, chemiluminescent immunoassay - for in vitro detection of antibodies to hepatitis b core antigen (anti-hbc) in clinical specimens for in vitro detection of antibodies to hepatitis b core antigen (anti-hbc) in clinical specimens

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - 48524 - human t-cell lymphotrophic virus 1 & 2 (htlv1 & htlv2) antibody ivd, kit, chemiluminescent immunoassay - the liaison? xl murex rechtlv-i/ii assay uses chemiluminescence immunoassay (clia) technology for the qualitative determination of specific antibodies to human t-cell lymphotropic virus (htlv) type i and type ii (anti-htlv-i and anti-htlv-ii) in human serum or plasma samples. for the qualitative determination of antibodies to human t-cell lymphotropic virus type 1 and/or type ii (htlv-i/ii) in human serum and plasma, including specimens collected up to 24 hours post mortem (non-heart beating).

Australia - English - Department of Health (Therapeutic Goods Administration)

paragon care group australia pty ltd trading as immulab - ct1040 - human platelet antigen (hpa) antibody screening and identification ivds - for use in solid phase assays for the detection of antibodies to platelets.

Australia - English - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - 48304 - hepatitis b virus core total antibody ivd, kit, chemiluminescent immunoassay - qualitative immunoassay integrated to the access immunoassay systems, for the detection of antibodies directed against hepatitis b core antigen in human serum or plasma the access hbc ab assay is a qualitative immunoassay integrated to the access immunoassay systems, for the detection of antibodies directed against hepatitis b core antigen in human serum or plasma.

Australia - English - Department of Health (Therapeutic Goods Administration)

integrated sciences pty ltd - 48454 - hiv1/hiv2 antibody ivd, kit, immunochromatographic test (ict), rapid - the oraquick advance ? hiv-1/2 test is a manually performed, visually read, 20 minute immunoassay for the qualitative detection of antibodies to hiv-1 and hiv-2. the assay test strip, contains synthetic peptides representing the hiv envelope region and a goat anti-human igg procedural control immobilized onto a nitrocellulose membrane in the test (t) zone and the control (c) zone, respectively intended to detect hiv antibodies in blood, oral fluid and plasma by ict

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - 48304 - hepatitis b virus core total antibody ivd, kit, chemiluminescent immunoassay - the advia centaur hbc total assay is an antigen bridging microparticle chemiluminometric immunoassay used for the detection of antibodies to hepatitis b core antigen in human serum or plasma. an in vitro diagnostic immunoassay for the qualitative determination of total antibodies to the core antigen of the hepatitis b virus (hbc total) in clinical specimens.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - 48452 - hiv1/hiv2 antibody ivd, kit, chemiluminescent immunoassay - the advia centaur hiv 1/o/2 enhanced assay is an antigen bridging microparticle chemiluminometric immunoassay used for the detection of antibodies to the human immunodeficiency virus type 1, including subtype o, and/or type 2 in serum or plasma. an in vitro diagnostic immunoassay for the qualitative determination of antibodies to the human immunodeficiency virus type 1, including subtype o, and/or type 2 in clinical specimens.

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - 48298 - hepatitis b virus core immunoglobulin m (igm) antibody ivd, kit, chemiluminescent immunoassay - the liaison? hbc igm assay uses chemiluminescence immunoassay (clia) technology for the qualitative determination of igm immunoglobulin to hepatitis b core antigen (igm anti-hbc) in human serum or plasma samples. for the qualitative determination of igm immunoglobulin to hepatitis b core antigen (igm anti-hbc) in human serum or plasma samples.

Australia - English - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - 48304 - hepatitis b virus core total antibody ivd, kit, chemiluminescent immunoassay - the liaison? anti-hbc assay uses chemiluminescent immunoassay (clia) technology for the qualitative determination of total antibodies to hepatitis b core antigen (anti-hbc) in human serum or plasma samples. for the qualitative determination of total antibodies to hepatitis b core antigen (anti-hbc) in human serum and plasma samples, including specimens collected up to 24 hours post-mortem (non-heart beating).

Australia - English - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - 61225 - treponema pallidum immunoglobulin g (igg)/igm antibody ivd, kit, agglutination - beckman coulter pk tp system is intended for the qualitative screening of blood donors for the detection of treponema pallidum igg and igm antibodies in human serum or edta plasma using the beckman coulter pk7300, automated microplate system. the test is based on the principle of agglutination and pattern recognition. the beckman coulter pk tp system utilizes fixed chicken erythrocytes sensitized with components of the pathogenic t. pallidum